{"id":"NCT00220961","sponsor":"The University of Texas Health Science Center at San Antonio","briefTitle":"Actos Now for Prevention of Diabetes (ACT NOW)","officialTitle":"Actos Now for Prevention of Diabetes (ACT NOW)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-01","primaryCompletion":"2010-04","completion":"2010-04","firstPosted":"2005-09-22","resultsPosted":"2016-08-11","lastUpdate":"2016-08-11"},"enrollment":602,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Impaired Glucose Tolerance","Type 2 Diabetes"],"interventions":[{"type":"DRUG","name":"Pioglitazone","otherNames":["Actos"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Pioglitazone","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to examine whether pioglitazone versus placebo can reduce the conversion rate of impaired glucose tolerance (IGT) to type 2 diabetes mellitus","primaryOutcome":{"measure":"Prevention of Type 2 Diabetes","timeFrame":"2.4 years","effectByArm":[{"arm":"Placebo","deltaMin":16.1,"sd":null},{"arm":"Pioglitazone","deltaMin":5,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":31},"locations":{"siteCount":8,"countries":["United States"]},"refs":{"pmids":["33210751","26982008","25603459","24705615","23175674","21428766","19640291"],"seeAlso":["http://www.diabetes.org/"]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":299},"commonTop":["Other","Myocardio infarction, heart failure, other"]}}